Overview

Women's Estrogen for Stroke Trial (WEST)

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:
0

Participant gender:

Summary

To determine if estrogen hormone replacement therapy reduces the risk of stroke or death in postmenopausal women who have already had stroke or a transient ischemic attack (TIA).

Phase:

Phase 3

Details

Lead Sponsor:

National Institute of Neurological Disorders and Stroke (NINDS)

Treatments:

Estrogens